NEWS
- Nectin-4: New Antibody-Drug Conjugate (ADC) Target
- Overview of Antidiabetic Drug Classifications and Future Trends
- Long Acting PEGylated Interferon: Application of PEG
- Nanovaccines: Current Advances and Challenges
- COVID-19 mRNA Vaccine Excipients - PEG Products Supply
- HER2 Targeted Therapies In Breast Cancer
- c-MET: A Novel Target for Anticancer Therapies
- Novel FRα-targeting Antibody-drug Conjugates (ADCs)
- Advantages and Disadvantages of PEGylated Liposomes in Drug Delivery System
- Anti-obesity Medications (AOMs): History And Progress
